Cargando…

Autoimmune Disease Prevalence in a Multiple Sclerosis Cohort in Argentina

Background. Comorbid autoimmune diseases in MS patients have been studied extensively with controversial results. Moreover, no such data exists for Latin-American MS patients. Methods. We conducted a case-control study aimed to establish the prevalence of autoimmune disorders in a cohort of Argentin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farez, Mauricio F., Balbuena Aguirre, María E., Varela, Francisco, Köhler, Alejandro A., Correale, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142150/ https://www.ncbi.nlm.nih.gov/pubmed/25170425 http://dx.doi.org/10.1155/2014/828162

Ejemplares similares

Obesity and the risk of Multiple Sclerosis. The role of Leptin
por: Marrodan, Mariano, et al.
Publicado: (2020)

The Role of Astrocytes in Multiple Sclerosis Progression
por: Correale, Jorge, et al.
Publicado: (2015)

Environmental factors influencing multiple sclerosis in Latin America
por: Correale, Jorge, et al.
Publicado: (2017)

Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?
por: Correale, Jorge, et al.
Publicado: (2012)

Mucosal-Associated Invariant T Cell Features and TCR Repertoire Characteristics During the Course of Multiple Sclerosis
por: Carnero Contentti, Edgar, et al.
Publicado: (2019)

Decision-making impairment in patients with multiple sclerosis: a case–control study
por: Farez, Mauricio F, et al.
Publicado: (2014)

Effects of Systolic Blood Pressure on Brain Integrity in Multiple Sclerosis
por: Dossi, Daiana E., et al.
Publicado: (2018)

Systems biology approaches for the study of multiple sclerosis
por: Quintana, Francisco J, et al.
Publicado: (2008)

Impact of Andropause on Multiple Sclerosis
por: Ysrraelit, Maria C., et al.
Publicado: (2021)

Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination
por: Correale, Jorge, et al.
Publicado: (2022)

Multiple sclerosis and obesity: The role of adipokines
por: Correale, Jorge, et al.
Publicado: (2022)

Immunosuppressive Amino-Acid Catabolizing Enzymes in Multiple Sclerosis
por: Correale, Jorge
Publicado: (2021)

Multiple Sclerosis Misdiagnosis: A Persistent Problem to Solve
por: Gaitán, María I., et al.
Publicado: (2019)

Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
por: Rojas, Juan I., et al.
Publicado: (2022)

The challenges and opportunities of multiple sclerosis care in Latin America
por: Ontaneda, Daniel, et al.
Publicado: (2017)

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
por: Correale, Jorge, et al.
Publicado: (2019)

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
por: Ysrraelit, Maria Celica, et al.
Publicado: (2021)

Are highly active and aggressive multiple sclerosis the same entity?
por: Correale, Jorge, et al.
Publicado: (2023)

Current Perspectives: Evidence to Date on BTK Inhibitors in the Management of Multiple Sclerosis
por: Carnero Contentti, Edgar, et al.
Publicado: (2022)

Autoimmunity – Multiple Sclerosis
por: Ances, Beau M., et al.
Publicado: (2005)

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain
por: Almusalam, Noora, et al.
Publicado: (2019)

Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
por: Ysrraelit, Maria C., et al.
Publicado: (2018)

Adaptive Autoimmunity and Foxp3-Based Immunoregulation in Zebrafish
por: Quintana, Francisco J., et al.
Publicado: (2010)

Is Multiple Sclerosis an Autoimmune Disease?
por: Wootla, Bharath, et al.
Publicado: (2012)

The Role of Autoimmunity in Multiple Sclerosis
por: Bradl, Monika, et al.
Publicado: (2005)

Multiple Sclerosis and Autoimmune Comorbidities
por: Nociti, Viviana, et al.
Publicado: (2022)

Co-occurrence of autoimmune thyroid disease in a multiple sclerosis cohort
por: Sloka, JS, et al.
Publicado: (2005)

Brain volume loss and physical and cognitive impairment in naïve multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina
por: Rojas, Juan Ignacio, et al.
Publicado: (2022)

Estimating the risk of COVID-19 in multiple sclerosis patients in Buenos Aires, Argentina
por: Cristiano, E, et al.
Publicado: (2020)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Virus-mediated autoimmunity in Multiple Sclerosis
por: Grigoriadis, Nikolaos, et al.
Publicado: (2006)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
por: Correale, Jorge, et al.
Publicado: (2016)

Argentina
por: Arias, Raúl Jorge

Multiple Sclerosis and Autoimmunity: A Veiled Relationship
por: Barkhane, Zineb, et al.
Publicado: (2022)

Changes in the Care of Neurological Diseases During the First Wave of the COVID-19 Pandemic: A Single Private Center Study in Argentina
por: Calandri, Ismael L., et al.
Publicado: (2021)

Use of Fingolimod in the Management of Relapsing–Remitting Multiple Sclerosis: Experience from Latin America
por: Correale, Jorge, et al.
Publicado: (2015)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Prevalence and characteristics of cutaneous sarcoidosis in Argentina
por: Abed Dickson, Marina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9k5qhnm5vlokkvlmmimrp2ks8f